TaxTMI Login
🎉 Festive Offer: Flat 15% off on all plans! →⚡ Don’t Miss Out: Limited-Time Offer →
TaxTMI 
Login
Just a moment...
Press 'Enter' to add multiple search terms. Rules for Better Search
of 
of 
No Folders have been created
Are you sure you want to delete "My most important" ?
NOTE:
of of 
All Notifications
of of All Notifications
Note
Bookmark
Share
Don't have an account? Register Here
of <h1>COVID-19 Medicines Get GST Relief: Nil Rate for Tocilizumab, Amphotericin B; Reduced Rate for Others Until Dec 2021.</h1> The Central Government, under the Union Territory Goods and Services Tax Act, 2017, has issued a notification exempting certain COVID-19 related medicines from Union Territory GST. Effective from October 1, 2021, until December 31, 2021, the exemption applies to specified medicines, including Tocilizumab and Amphotericin B, which are taxed at a nil rate. Other medicines such as Remdesivir, Heparin, and Favipiravir are subject to a reduced tax rate of 2.5%. This measure aims to alleviate the financial burden on essential COVID-19 treatments.
TaxTMI 
